New program aims to cut heart risk in rheumatoid arthritis patients
NCT ID NCT04488497
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a program to help people with rheumatoid arthritis (RA) get their cholesterol checked and treated. Many RA patients are at higher risk for heart attacks and strokes but often miss out on proper screening. The program used peer coaches and educational materials to encourage cholesterol testing. 101 participants completed the study, and researchers measured how many got their lipids checked.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
peer coaching and educational materials
What this could lead to
If successful, this program could help more rheumatoid arthritis patients get their cholesterol checked and treated, potentially lowering their risk of heart attacks and strokes.
What could go wrong
This was a small, early-stage pilot study with only 101 participants. The intervention is behavioral, so results may vary widely and may not apply to all patients. It does not test a new drug or treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIOVASCULAR DISEASES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Weill Cornell Medicine
New York, New York, 10021, United States